Clinical Trial Update: Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer [NA]

View source ↗

Summary

Clinical trial evaluating zoledronate for osteopenia or osteoporosis in postmenopausal women with breast cancer receiving letrozole; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteoporosis

Drugs mentioned

• Zoledronate (zoledronic acid)

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Cancer, Osteoporosis | NA | Status: COMPLETED | Results posted: 2011-08-12